Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Purpose

This clinical trial evaluates the impact of a patient-centered health and wellness coaching (HWC) intervention on adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer. Treatment for thyroid cancer often involves surgery, radioactive iodine and/or lifelong levothyroxine with regular monitoring of thyroid stimulating hormone levels. Despite strong survival rates, patients frequently report fatigue, cognitive issues, mood changes, and disruptions in daily life. Treatment burden and psychosocial strain often impair the ability to follow the treatment plan and healthy lifestyle. Studies have shown that HWC motivates patients to take ownership and accountability to perform positive and healthy behavioral changes. HWC may have a positive impact on health-related goal-setting processes and improve self-care and healthcare outcomes in certain settings. It is not yet known how HWC impacts thyroid cancer patients. Incorporating HWC into survivorship care may improve adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer.

Conditions

  • Thyroid Gland Follicular Carcinoma
  • Thyroid Gland Papillary Carcinoma

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults ≥ 18 years - Histologically confirmed papillary or follicular thyroid carcinoma - Status post total thyroidectomy ± radioactive iodine therapy - Receiving levothyroxine monotherapy (no triiodothyronine [T3] or desiccated thyroid products) - Thyroid-stimulating hormone (TSH) < 4 uIU/mL at ≥ 3 months post-thyroidectomy - English proficiency - Ability to provide informed consent

Exclusion Criteria

  • Medullary or anaplastic thyroid carcinoma - Current systemic therapy for thyroid or other cancers - Cognitive or psychiatric impairment precluding participation - Inability to complete study procedures

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Supportive care (HWC)
Patients attend an initial HWC session over 60 minutes and then attend follow-up HWC sessions over 20-60 minutes each monthly for up to 5 months.
  • Other: Counseling
    Attend HWC sessions
    Other names:
    • Counseling Intervention
  • Other: Interview
    Ancillary studies
  • Other: Questionnaire Administration
    Ancillary studies

Recruiting Locations

Mayo Clinic in Florida
Jacksonville, Florida 32224-9980
Contact:
Clinical Trials Referral Office
855-776-0015
mayocliniccancerstudies@mayo.edu

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Clinical Trials Referral Office
855-776-0015
mayocliniccancerstudies@mayo.edu